BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38812995)

  • 1. Correlation of metal ions with specific brain region volumes in neurodegenerative diseases.
    Melek İM; Kuş B; Kaptan Z; Petekkaya E
    Turk J Med Sci; 2023; 53(5):1465-1475. PubMed ID: 38812995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Casanova F; Tian Q; Williamson DS; Qian Y; Zweibaum D; Ding J; Atkins JL; Melzer D; Ferrucci L; Pilling LC
    Neurobiol Dis; 2024 Jul; 197():106539. PubMed ID: 38789058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases.
    Bartzokis G; Tishler TA; Shin IS; Lu PH; Cummings JL
    Ann N Y Acad Sci; 2004 Mar; 1012():224-36. PubMed ID: 15105269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
    Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC
    Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
    Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
    Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
    Jakimovski D; Bergsland N; Dwyer MG; Hagemeier J; Ramasamy DP; Szigeti K; Guttuso T; Lichter D; Hojnacki D; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    Neurobiol Aging; 2020 Jun; 90():84-92. PubMed ID: 32147244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
    Dexter DT; Jenner P; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S94-100. PubMed ID: 1510387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)].
    Johannesson T; Kristinsson J; Torsdottir G; Snaedal J
    Laeknabladid; 2012 Oct; 98(10):531-7. PubMed ID: 23043066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment.
    Gao L; Jiang Z; Cai Z; Cai M; Zhang Q; Ma Y; Li G; Zhao F; Ma Q
    Mol Med Rep; 2017 Dec; 16(6):8209-8215. PubMed ID: 28990041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of endocannabinoids in olfactory and taste dysfunctions in Alzheimer's and Parkinson's patients and volumetric changes in the brain.
    Petekkaya E; Kuş B; Doğan S; Bayaroğulları H; Mutlu T; Murat Melek İ; Arpacı A
    J Clin Neurosci; 2022 Jun; 100():52-58. PubMed ID: 35398594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in iron load in specific brain areas lead to neurodegenerative diseases of the central nervous system.
    Wang X; Zhu Z; Sun J; Jia L; Cai L; Chen Q; Yang W; Wang Y; Zhang Y; Guo S; Liu W; Yang Z; Zhao P; Wang Z; Lv H
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110903. PubMed ID: 38036035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer's Disease.
    Pu Z; Xu W; Lin Y; He J; Huang M
    Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):353-359. PubMed ID: 28554217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
    Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
    Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.
    Thaler A; Kliper E; Maidan I; Herman T; Rosenberg-Katz K; Bregman N; Gurevich T; Shiner T; Hausdorff JM; Orr-Urtreger A; Giladi N; Mirelman A
    Brain Topogr; 2018 Nov; 31(6):1029-1036. PubMed ID: 29846835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases.
    Blanc F; Noblet V; Philippi N; Cretin B; Foucher J; Armspach JP; Rousseau F;
    PLoS One; 2014; 9(12):e114774. PubMed ID: 25479196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical nuclei in Alzheimer's disease: a volumetric and diffusion kurtosis imaging study.
    Wang ML; Wei XE; Fu JL; Li W; Yu MM; Li PY; Li WB
    Acta Radiol; 2018 Nov; 59(11):1365-1371. PubMed ID: 29482345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.